IRadimed

IRadimed EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of IRadimed (IRMD) as of Oct 11, 2026 is 71.31. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 69.47 — a change of 2.64% (higher).

EV/FCF

71.31

YoY

2.64%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of IRadimed is 2025 71.31 . EV/FCF (Enterprise Value to Free Cash Flow) of IRadimed was 2024 69.47 . It decreases by 2.64% higher compared to the previous year.

The IRadimed EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
174.64 USD
Jan 1, 2019
126.20 USD
Jan 1, 2020
236.33 USD
Jan 1, 2021
115.42 USD
Jan 1, 2022
149.17 USD
Jan 1, 2023
224.74 USD
Jan 1, 2024
69.47 USD
Jan 1, 2025
71.31 USD
The IRadimed EV/FCF history
YEAREV/FCFYoY
71.31+2.64%
69.47-69.09%
224.74+50.66%
149.17+29.24%
115.42-51.16%
236.33+87.26%
126.20-27.74%
174.64-63.80%
482.41+204.03%
158.67-6.85%
170.34-73.22%
636.03—
Access this data via the Eulerpool API

IRadimed Stock analysis

What does IRadimed do? IRadimed Corp is an American company specializing in the development, manufacturing, and marketing of advanced medical technology products. The company was founded in 1992 and is headquartered in Winter Springs, Florida. It was founded to meet the need for advanced and precise medical devices used in intensive care. In recent years, the company has focused on the development of components and accessory products for magnetic resonance imaging (MRI) used in radiology and oncology. IRadimed Corp is known for its innovative and technologically advanced approach to the medical technology industry. The company prioritizes research and development and collaborates closely with clinics, hospitals, and medical facilities to provide the best solutions for patient care. It has a strong distribution network that allows its products to be distributed worldwide, particularly in the United States, Europe, and Asia. The company offers a wide range of medical devices and accessory products used in radiology, oncology, and other medical fields. Its specialty lies in manufacturing components and accessories for MRI. These include MRI-compatible infusion pumps, patient monitoring devices, ventilation devices, and coil arrays designed for imaging the skull and spine, as well as breast and prostate imaging. In summary, IRadimed Corp is a leading provider of medical devices and accessories for radiology, oncology, and other specialized fields. Its focus on MRI-compatible devices and accessories, as well as its collaborative approach with medical facilities, sets it apart in the industry. The company prides itself on innovation and technological advancement, offering a wide range of products tailored to the needs of patients and medical professionals. IRadimed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IRadimed stock

EV/FCF (Enterprise Value to Free Cash Flow) of IRadimed is 71.31 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of IRadimed changed from 69.47 to 71.31, representing a 2.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) IRadimed since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s IRadimed with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — IRadimed

All Key Metrics — IRadimed